Company / R&D per Share
DNA X, Inc. R&D per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.40
FY2024
5-year range
$0.20 / $2.45
FY2020-FY2024
Trend
+104.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share returned to growth in FY2024 after 2 years of decline, reaching $0.40.
Based on SEC 10-K filings.
0.40 in FY2024 with a 5-year CAGR of -23.1%.
Declined from $0.94 to $0.40 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -45.3%
- 5-Year CAGR
- -23.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, r&d per share increased 104.7% year-over-year.
- Peak r&d per share was recorded in FY2021.
- Lowest r&d per share in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.40 | +104.7% |
| FY2023 | $0.20 | -79.2% |
| FY2022 | $0.94 | -61.5% |
| FY2021 | $2.45 | +91.8% |
| FY2020 | $1.28 | -14.5% |
| FY2019 | $1.49 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026